Literature DB >> 22968543

Iron content of the pulvinar nucleus of the thalamus is increased in adolescent multiple sclerosis.

Jesper Hagemeier1, E Ann Yeh, Mari Heininen Brown, Niels Bergsland, Michael G Dwyer, Ellen Carl, Bianca Weinstock-Guttman, Robert Zivadinov.   

Abstract

OBJECTIVE: The objective of this paper is to assess abnormal phase values, indicative of increased iron content, using susceptibility-weighted imaging (SWI)-filtered phase of the subcortical deep gray matter (SDGM) in adolescent multiple sclerosis (MS) and other neurological disorders (OND) patients, and in healthy controls (HC).
METHODS: Twenty adolescent MS and eight adolescent OND patients and 21 age- and sex-matched HC were scanned on a 3T GE scanner. Mean phase of abnormal phase tissue (MP-APT), MP-APT volume, normal phase tissue volume (NPTV) and normalized volume measurements were obtained for total SDGM, as well as specific structures separately.
RESULTS: Significantly increased MP-APT (28.2%, p<.001) and MP-APT volume (82.7%, p<.001), and decreased NPTV (-23.3%, p<.001) and normalized volume (-15.5%, p<.001) in the pulvinar nucleus of the thalamus was found in MS patients compared to HC. MP-APT in MS patients was also increased in total SDGM (p=.012) and thalamus (p=.044). Compared to OND patients, MS patients had increased MP-APT volume in the pulvinar nucleus of the thalamus (p=.044) and caudate (p=.045). Increased MP-APT of the SDGM structures were associated with increased T2 and T1 lesion burden and brain atrophy in MS patients.
CONCLUSION: Adolescent MS patients showed increased iron content in the SDGM compared to OND patients and HC.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22968543     DOI: 10.1177/1352458512459289

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  11 in total

1.  Hemoglobin as a source of iron overload in multiple sclerosis: does multiple sclerosis share risk factors with vascular disorders?

Authors:  Vladimir V Bamm; George Harauz
Journal:  Cell Mol Life Sci       Date:  2014-02-07       Impact factor: 9.261

2.  Early silent microstructural degeneration and atrophy of the thalamocortical network in multiple sclerosis.

Authors:  Michael Deppe; Julia Krämer; Jan-Gerd Tenberge; Jasmin Marinell; Wolfram Schwindt; Katja Deppe; Sergiu Groppa; Heinz Wiendl; Sven G Meuth
Journal:  Hum Brain Mapp       Date:  2016-02-27       Impact factor: 5.038

3.  A pilot, longitudinal, 24-week study to evaluate the effect of interferon beta-1a subcutaneous on changes in susceptibility-weighted imaging-filtered phase assessment of lesions and subcortical deep-gray matter in relapsing-remitting multiple sclerosis.

Authors:  Robert Zivadinov; Michael Dwyer; Silva Markovic-Plese; Brooke Hayward; Niels Bergsland; Mari Heininen-Brown; Ellen Carl; Cheryl Kennedy; Fernando Dangond; Bianca Weinstock-Guttman
Journal:  Ther Adv Neurol Disord       Date:  2015-03       Impact factor: 6.570

4.  Mapping of thalamic magnetic susceptibility in multiple sclerosis indicates decreasing iron with disease duration: A proposed mechanistic relationship between inflammation and oligodendrocyte vitality.

Authors:  Ferdinand Schweser; Ana Luiza Raffaini Duarte Martins; Jesper Hagemeier; Fuchun Lin; Jannis Hanspach; Bianca Weinstock-Guttman; Simon Hametner; Niels Bergsland; Michael G Dwyer; Robert Zivadinov
Journal:  Neuroimage       Date:  2017-10-31       Impact factor: 6.556

5.  Thalamic Iron Differentiates Primary-Progressive and Relapsing-Remitting Multiple Sclerosis.

Authors:  A Burgetova; P Dusek; M Vaneckova; D Horakova; C Langkammer; J Krasensky; L Sobisek; P Matras; M Masek; Z Seidl
Journal:  AJNR Am J Neuroradiol       Date:  2017-04-27       Impact factor: 3.825

6.  Quantitative Susceptibility Mapping of the Thalamus: Relationships with Thalamic Volume, Total Gray Matter Volume, and T2 Lesion Burden.

Authors:  G C Chiang; J Hu; E Morris; Y Wang; S A Gauthier
Journal:  AJNR Am J Neuroradiol       Date:  2018-01-25       Impact factor: 3.825

7.  Iron and volume in the deep gray matter: association with cognitive impairment in multiple sclerosis.

Authors:  C M Modica; R Zivadinov; M G Dwyer; N Bergsland; A R Weeks; R H B Benedict
Journal:  AJNR Am J Neuroradiol       Date:  2014-06-19       Impact factor: 3.825

Review 8.  Iron chelation and multiple sclerosis.

Authors:  Kelsey J Weigel; Sharon G Lynch; Steven M LeVine
Journal:  ASN Neuro       Date:  2014-01-30       Impact factor: 4.146

9.  Early and Degressive Putamen Atrophy in Multiple Sclerosis.

Authors:  Julia Krämer; Sven G Meuth; Jan-Gerd Tenberge; Patrick Schiffler; Heinz Wiendl; Michael Deppe
Journal:  Int J Mol Sci       Date:  2015-09-25       Impact factor: 5.923

Review 10.  Thalamic lesions: a radiological review.

Authors:  Dimitri Renard; Giovanni Castelnovo; Chantal Campello; Stephane Bouly; Anne Le Floch; Eric Thouvenot; Anne Waconge; Guillaume Taieb
Journal:  Behav Neurol       Date:  2014-07-02       Impact factor: 3.342

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.